policy+practice

This new partnership between the health regulatory authorities of the EU and Brazil is an important step towards mutual recognition and regulatory harmonisation to improve human and animal health.

The agreements will bolster India's arsenal of drugs to battle its catastrophic second wave of the pandemic, which has led to an acute shortage of coronavirus medicines including remdesivir and tocilizumab.

The potential cost-effectiveness estimates are significantly higher than what NICE considers to be an appropriate use of NHS resources.

Controversial move to waive patent protections for vaccines is a key element.

Concerns have risen on potential side-effects of the Anglo-Swedish COVID-19 vaccine.

Western pharmaceutical companies, many of which have received government support to develop vaccines, strongly oppose the transfer of intellectual property to make them.

The new system in New Zealand will be up and running within two years.

Democrats have no workable plan to tackle the cost of prescription drugs, even with full control of Washington and after campaigning on the issue for years.

California’s dentist and doctor lobbies say insurance companies are flush with cash after collecting premiums during the pandemic but paying fewer claims than usual—and should foot the bill.

Despite the industry’s lobbying efforts, the Biden administration bowed to intense pressure at home and abroad and announced support for temporarily waiving international patent protections for COVID vaccines and manufacturing technology. 

Innovators and entrepreneurs, scientists and CEOs reacted with deep concern to the Biden administration’s decision this week to support temporarily waiving intellectual property rights for COVID-19 vaccines.

There is now a broad consensus in the Democratic party that something needs to be done about drug prices. What the president has just done is show it can be done.

The talks also are likely to focus on a waiver that is significantly narrower in scope and shorter in duration than the one initially proposed by India and South Africa last October.

Friday's death comes as the country is battling a new outbreak that began early last week and is spreading rapidly in many parts of the country, including the capital Hanoi.

Drug makers must face claims by purchasers that they conspired to suppress generic competition through an illegal patent settlement.